At CRISPR Therapeutics, we are focused on developing transformative gene-based medicines for serious human diseases
We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-editing platform into therapies to treat hemoglobinopathies, cancer, diabetes and other diseases
Our multi-disciplinary team of world-class researchers and drug developers works every day to translate our CRISPR/Cas9 technology into breakthrough human therapeutics. We are advancing a variety of programs across our four core franchises: hemoglobinopathies, immuno-oncology, regenerative medicine, and in vivo.
Building a great company with a focus on science, innovation, collaboration and entrepreneurship
Our revolutionary technology provides the foundation for building a sustainable innovation engine and a place to foster entrepreneurship across all fronts. We’re always looking for talented, experienced and passionate individuals to join us. We have our headquarters in Zug, Switzerland, our R&D operations in Boston, Massachusetts, USA, manufacturing operations in Framingham, Massachusetts, USA, and additional business operations in San Francisco, California. Please visit the careers page for more information.
Our management team has experience across all aspects of drug development and commercialization
We are looking for energetic and talented people who like challenges and want to make a difference
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.